Wharton’s Jelly Mesenchymal Stem Cell Administration Improves Quality of Life and Self-Sufficiency in Children with Cerebral Palsy: Results from a Retrospective Study
The aim of this paper was to describe the outcome of the therapeutic administration of allogenic mesenchymal stem cells obtained from Wharton’s jelly (WJ-MSCs) in children with cerebral palsy (CP) during a medical therapeutic experiment. We retrospectively analyzed the records of 109 patients recrui...
Main Authors: | Dariusz Boruczkowski, Izabela Zdolińska-Malinowska |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2019/7402151 |
Similar Items
-
Autologous cord blood in children with cerebral palsy: a review
by: Dariusz Boruczkowski, et al.
Published: (2019-05-01) -
The use of umbilical cord‐derived mesenchymal stem cells in patients with muscular dystrophies: Results from compassionate use in real‐life settings
by: Beata Świątkowska‐Flis, et al.
Published: (2021-10-01) -
Characterization and plasticity of wharton's jelly mesenchymal stem cells of goat
by: Gustavo Cardoso da Silva Neves, et al.
Published: (2021-01-01) -
Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization
by: Hossein Ranjbaran, et al.
Published: (2018-02-01) -
AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
by: Renata Szydlak, et al.
Published: (2019-09-01)